Kreaxi

Kreaxi, founded in 2016 and headquartered in Lyon and Paris, France, is an investment management firm that specializes in the equity financing of innovative, deep tech, and low-tech startups with high growth potential. The firm primarily focuses on early-stage investments, including seed and Series A funding rounds, with investment sizes ranging from €100k to €2.5m. Kreaxi has made 68 investments and achieved 7 notable exits, including companies like Per Angusta, Wattsense, and Aster App. Their portfolio includes a diverse range of sectors, such as health care, artificial intelligence, renewable energy, and software development. Notable investments include Ciliatech, a medical technology company, Previa Medical, which focuses on AI-driven health care solutions, and HySiLabs, a renewable energy firm. Kreaxi's approach is to provide comprehensive support to its portfolio companies, including strategic advice, access to a vast network, and assistance in scaling operations. The firm manages regional funds in France, with a strong presence in the Auvergne-Rhône-Alpes region, as well as French and pan-European funds.